Establishes the "Veterans Mental Health Innovation Act" relating to ibogaine treatment
- Introduced Jan 20, 2026
- In committee Feb 5, 2026
- Died
- Passed the House
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
SB 1581 - This act establishes the "Veterans Mental Health Innovation Act". Under this act, the Department of Health and Senior Services shall, subject to appropriation, award grants to conduct certified clinical drug development trials overseen by the U.S. Food and Drug Administration (FDA) on the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other…
Read the full title (315 words)
SB 1581 - This act establishes the "Veterans Mental Health Innovation Act". Under this act, the Department of Health and Senior Services shall, subject to appropriation, award grants to conduct certified clinical drug development trials overseen by the U.S. Food and Drug Administration (FDA) on the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy. Grantees shall meet the eligibility requirements set forth in the act, including having signed an agreement with a consortium established by another state that has submitted specified applications and requests with the FDA. This act creates the "Ibogaine Study Fund" in the state treasury for the disbursement of grants under this act. Selected grant applicants shall submit quarterly reports to the Department and the Department shall submit an annual report to the General Assembly on the progress of the trials. This act also creates the "Ibogaine Intellectual Property Fund" for all revenue attributable to all intellectual property rights and other commercial rights that may arise from drug development clinical trials conducted by a multistate consortium under this act during the period for which the trials are funded and any following period of commercialization. The moneys in the fund shall be used solely for programs that assist veterans or other at-risk populations in this state. If ibogaine is approved by the FDA to treat a medical condition, only a licensed physician shall prescribe it for a patient and a licensed physician shall supervise its administration at a hospital or other licensed health care facility. The Department shall begin accepting grant applications before November 1, 2026, but may delay implementation of some or all of the provisions of this act if the Department determines that a waiver or authorization from a federal agency is first necessary. This act is identical to HB 2961 (2026).
Every action
4 steps, oldest first, as the legislature records them.
- SenateS First Read
- CommitteeSecond Read and Referred S Veterans and Military Affairs Committee · Senate Veterans and Military Affairs
- CommitteeHearing Conducted S Veterans and Military Affairs Committee · Senate Veterans and Military Affairs
- CommitteeVoted Do Pass S Veterans and Military Affairs Committee · Senate Veterans and Military Affairs
Roll calls
1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.
Committee votes
| Date | Where | Question | Result |
|---|---|---|---|
| Apr 1, 2026 | Senate Veterans and Military Affairs | Veterans and Military Affairs: To pass the bill out - Regular MembersYes · 3 No · 1 Absent · 2 |
3–1 |
Sponsors
The member who introduced it.
-
Jason BeanR Primary sponsor · District 25
From Missouri's official records (www.senate.mo.gov), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.